Quarterly report pursuant to Section 13 or 15(d)

Equity Transactions (Details Narrative)

v3.20.2
Equity Transactions (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Jul. 24, 2020
Feb. 05, 2020
Sep. 30, 2020
Apr. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Warrant to purchase of common stock     1,965,594     1,965,594  
Warrant exercise price     $ 1.10     $ 1.10  
Value of shares issued for services     $ 230,000   $ 202,000 $ 1,126,000 $ 930,000
Series A Shareholders [Member]              
Warrant to purchase of common stock   2,303,861          
Warrant term   5 years          
Warrant exercise price   $ 1.20          
Fair value derivative liability upon issuance   $ 3,951,000          
Vendors [Member]              
Number of shares issued for services           962,583  
Value of shares issued for services           $ 1,126,000  
Common Stock [Member]              
Sale and issuance of common stock     12,545,453   12,545,453 6,549,596
Stock issued during period, shares           4,237,833  
Number of shares issued for services     193,533   156,478 962,583 354,288
Value of shares issued for services      
Private Placement [Member]              
Common per-share price   $ 1.20          
Sale and issuance description   The sale and issuance of up to five million shares of our Common Stock at a per-share price of $1.20 (represents a 20% discount to the $1.50 closing price of our Common Stock on that day          
Cash fee aggregate amount   $ 499,000          
Private placement description   Our Private Placement was managed by the Company; however, in connection with our Closings, we paid a non-U.S. based consultant (i) as a cash fee, an aggregate amount of $499,000 (or 10% of the gross proceeds of our Closings), (ii) as a non-accountable expense allowance, an aggregate of $99,000 (or 2% of the gross proceeds of our Closings), (iii) five-year warrants, exercisable for an aggregate of up to 416,199 shares of our Common stock at a cash-only exercise price of $1.92 per share, and (iv) 100,000 shares of our Common Stock. We made the above-referenced payments only in respect of that portion of the gross proceeds from our Closings for investors introduced to us by the consultant.          
Share based compensation expense   $ 42,000          
Private Placement [Member] | Common Stock [Member]              
Sale and issuance of common stock       4,237,833      
Proceeds sold of common stock       $ 4,444,000      
Private Placement [Member] | Maximum [Member]              
Sale and issuance of common stock   5,000,000          
Public Offering [Member] | Common Stock [Member]              
Stock issued during period, shares 12,545,453            
Proceeds from issuance of stock $ 12,337,000            
Public Offering [Member] | Common Stock [Member] | Overallotment Option [Member]              
Stock issued during period, shares 1,636,363